Aesculap Implant Systems

What Aesculap Implant Systems does

Aesculap Implant Systems, LLC was a medical device company specializing in orthopedic and spine implants and surgical instrumentation, operating as a wholly-owned subsidiary of B. Braun of America Inc. from Center Valley, Pennsylvania. Its core product portfolio comprised knee replacement systems (VEGA System Knee, Columbus Knee, and Columbus AS Revision Knee System), hip endoprosthetics, the activL spine technology portfolio (including the activL artificial disc), and the OrthoPilot computer-assisted surgery navigation platform, alongside broader surgical instruments, motor systems, endoscopy, cranial implants, neurosurgical systems, and orthobiologics.

The company sold directly to orthopedic and spine surgeons and healthcare facilities via an enterprise field-sales motion, with sales representatives and customer service supporting hospitals and surgical centers on quote-based B2B terms (net-30 payment, no publicly disclosed pricing). Revenue was generated through one-time hardware sales of implants and instrumentation; revenue figures were not publicly disclosed. The company ceased U.S. orthopedic product sales on April 1, 2024, discontinued spine portfolio marketing on September 30, 2024, and announced final business closure on April 1, 2025, while continuing short-term distribution of knee polyethylene components for existing patients. In November 2025, the entity agreed to a $38.5 million settlement with the U.S. Department of Justice resolving long-standing federal investigations into faulty knee replacement devices, unapproved medical devices, and unlawful payments to induce device usage.

Name

Aesculap Implant Systems

Legal name

Aesculap Implant Systems, LLC

Website

https://aesculapimplantsystems.com

Company type

Private

Founded year

1867

Operating status

Closed

Headcount range

501–1,000 employees

Short description

Aesculap Implant Systems, LLC was a B. Braun subsidiary that manufactured and sold orthopedic (knee and hip) and spine implants and surgical instrumentation directly to U.S. hospitals and surgeons. The company ceased U.S. orthopedic sales in April 2024, discontinued spine products in September 2024, and closed on April 1, 2025.

Ownership category

akta.pro rank

Product category

Orthopedic Medical Devices

NAICS

Surgical Appliance and Supplies Manufacturing (339113), Surgical and Medical Instrument Manufacturing (339112)

SIC

Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Orthopedic Joint Reconstruction Implants (Hip/Knee/Shoulder/Elbow/Ankle) (HLAHAEAA)

akta.pro secondary industry

Surgical Navigation, Robotics & Patient-Matched Instrumentation (Ortho/Spine) (HLAHAEAL)

Keywords

• Orthopedic implants
• Spine surgery devices
• Knee replacement systems
• Hip replacement systems
• Surgical navigation technology

Headquarters

HQ city

Center Valley

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Medical Device Sales: Sale of orthopedic and spine implants and surgical instruments to healthcare facilities. The company sold hip and knee replacement systems, spinal implants, and associated surgical instrumentation directly to hospitals and surgical centers. Revenue was generated through one-time product sales with net-30 payment terms.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Core offering

Aesculap Implant Systems manufactured and sold orthopedic and spine implants, including knee replacement systems (VEGA System Knee, Columbus Knee, Columbus AS Revision Knee System), hip endoprosthetics, spinal implants and motion preservation products (including activL artificial disc technology), and associated surgical instrumentation. The portfolio also included OrthoPilot computer-assisted surgery navigation hardware and was sold to hospitals, surgical centers, and orthopedic and spine surgeons in the United States.

Product overview

Aesculap Implant Systems, LLC is a B. Braun company specializing in medical devices for orthopedics and spine surgery. The company operated a unified product portfolio spanning knee and hip endoprosthetics (VEGA System Knee, Columbus Knee, Columbus AS Revision Knee System), spine surgery products (including activL technology), computer-assisted surgery navigation (OrthoPilot), and general surgical instruments. Following business closure on April 1, 2025, the company ceased sales of orthopedic products (hip and knee systems) as of April 1, 2024 and spine products as of September 30, 2024, with only limited knee polyethylene component replacements continuing short-term. Strategic partnership options for the spine portfolio are being explored. The remaining active offerings center on post-market support for existing patients through polyethylene component replacements.

Differentiator

Problem solved

Functional benefit

Brands

• VEGA System: Knee system product line
• Columbus Knee
• Columbus AS Revision Knee System
• activL

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

One partnership is on record.

• B. Braun of America Inc.coreOthersAesculap Implant Systems is a subsidiary of B. Braun of America Inc. Parent company provides corporate ethics and compliance oversight, quality management systems, and shared administrative infrastructure. Aesculap, Inc. maintains the aesculapimplantsystems.com website as part of the B. Braun corporate family.

Scale indicators2 records

Recent moves5 records

Expansion highlights2 records

Direct peers

• NuVasive: Spine surgery specialist with motion preservation and cervical/lumbar disc technologies that compete in the same segment as Aesculap's activL artificial disc product.
• Stryker: Major orthopedic implant manufacturer with comprehensive knee, hip, and trauma portfolios plus the Mako surgical robotics platform that competes directly with Aesculap's OrthoPilot navigation technology.
• Smith+Nephew: UK-based orthopedic device company with knee, hip, and sports medicine offerings that directly overlap Aesculap's recon portfolio and compete in US hospital channels.
• DJO / Enovis: Orthopedic devices and bracing company with surgical implant and recon lines plus bracing/orthotics that overlap portions of the broader Aesculap recon and orthopedics portfolio.
• DePuy Synthes (Johnson & Johnson): J&J's orthopedic and spine division with knee/hip implants and spine hardware directly comparable to Aesculap's recon and activL spine portfolios. Competed head-to-head in the US recon and spine markets.
• Exactech: Specialty orthopedic implant company focused on knee, hip, and extremities that competed with Aesculap in primary and revision arthroplasty, particularly with its own revision knee system comparable to Columbus AS Revision Knee.
• Globus Medical: Spine-focused implant and enabling technology company that competes in US spine markets and would be a logical strategic buyer or partner for the activL disc technology being explored for external partnership.
• Zimmer Biomet: Global leader in knee and hip joint reconstruction implants with primary/revision systems directly overlapping Aesculap's VEGA and Columbus Knee portfolios. One of the closest direct competitors in the US orthopedic implant space where AIS ceased sales.

Broad incumbents

• Medtronic (Spine & Biologics): Diversified medical device leader with one of the largest spine surgery franchises, competing directly with Aesculap's activL artificial disc and broader spine portfolio in US hospitals.

Emerging players

• ConforMIS: Patient-specific knee implant manufacturer that overlaps with Aesculap's recon franchise and uses 3D-printed/custom technology that competes with broader industry shifts toward personalized orthopedics.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/aesculap-us

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Aesculap Implant Systems